Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00208_DB00726> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00208_DB00726 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00208_DB00726 label "DDI between Ticlopidine and Trimipramine - The strong CYP2C19 inhibitor, ticlopidine, may decrease the metabolism and clearance of trimipramine, a CYP2C19 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of trimipramine if ticlopidine is initiated, discontinued or dose changed. [drugbank_resource:DB00208_DB00726]" assertion.
- drugbank_resource:DB00208_DB00726 identifier "drugbank_resource:DB00208_DB00726" assertion.
- drugbank_resource:DB00208_DB00726 title "DDI between Ticlopidine and Trimipramine - The strong CYP2C19 inhibitor, ticlopidine, may decrease the metabolism and clearance of trimipramine, a CYP2C19 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of trimipramine if ticlopidine is initiated, discontinued or dose changed." assertion.